Skip Navigation

Human Molecular Genetics 2007 16(R1):R50-R59; doi:10.1093/hmg/ddm018
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Esteller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esteller, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Epigenetic gene silencing in cancer: the DNA hypermethylome

Manel Esteller*

Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain

* To whom correspondence should be addressed at: Tel: +34 912246940; Fax: +34 912246923; Email: mesteller{at}cnio.es

Received January 9, 2007; Accepted January 19, 2007

Epigenetic gene inactivation in transformed cells involves many ‘belts of silencing’. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
J. H. Lee, J. Gaetz, B. Bugarija, C. J. Fernandes, G. E. Snyder, E. C. Bush, and B. T. Lahn
Chromatin analysis of occluded genes
Hum. Mol. Genet., July 15, 2009; 18(14): 2567 - 2574.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K.-H. Huang, S.-F. Huang, I-H. Chen, C.-T. Liao, H.-M. Wang, and L.-L. Hsieh
Methylation of RASSF1A, RASSF2A, and HIN-1 Is Associated with Poor Outcome after Radiotherapy, but not Surgery, in Oral Squamous Cell Carcinoma
Clin. Cancer Res., June 15, 2009; 15(12): 4174 - 4180.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
K J Dudley, K Revill, R N Clayton, and W E Farrell
Pituitary tumours: all silent on the epigenetics front
J. Mol. Endocrinol., June 1, 2009; 42(6): 461 - 468.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Datta, K. Ghoshal, W. A. Denny, S. A. Gamage, D. G. Brooke, P. Phiasivongsa, S. Redkar, and S. T. Jacob
A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
Cancer Res., May 15, 2009; 69(10): 4277 - 4285.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
E. Gunduz, M. Gunduz, L. Beder, H. Nagatsuka, K. Fukushima, R. Sutcu, N. Delibas, N. Yamanaka, K. Shimizu, and N. Nagai
Downregulation of TESTIN and Its Association With Cancer History and a Tendency Toward Poor Survival in Head and Neck Squamous Cell Carcinoma
Arch Otolaryngol Head Neck Surg, March 1, 2009; 135(3): 254 - 260.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. L. Ostrow, H. L. Park, M. O. Hoque, M. S. Kim, J. Liu, P. Argani, W. Westra, W. V. Criekinge, and D. Sidransky
Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer
Clin. Cancer Res., February 15, 2009; 15(4): 1184 - 1191.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
D. L. Foley, J. M. Craig, R. Morley, C. J. Olsson, T. Dwyer, K. Smith, and R. Saffery
Prospects for Epigenetic Epidemiology
Am. J. Epidemiol., February 15, 2009; 169(4): 389 - 400.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
M. G. Guenther, L. N. Lawton, T. Rozovskaia, G. M. Frampton, S. S. Levine, T. L. Volkert, C. M. Croce, T. Nakamura, E. Canaani, and R. A. Young
Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia
Genes & Dev., December 15, 2008; 22(24): 3403 - 3408.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
A. Hudder and R. F. Novak
miRNAs: Effectors of Environmental Influences on Gene Expression and Disease
Toxicol. Sci., June 1, 2008; 103(2): 228 - 240.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.